Jurgen Figys

Brussels Court Of Appeal Prohibits The Rebranding Of A Generic Pharmaceutical Into The Originator Reference Product In The Framework Of Parallel Import

European Court Of Justice Issues Landmark Judgments Regarding Trademark Enforcement In Parallel Imports Of Generic Pharmaceuticals: No Repackaging/Rebranding As The Originator Reference Product

Unveiling The Complexity Of The Belgian MedTech Legal Landscape